Saturday November 18th 2017

Archive for September, 2017

Merck KGaA eyes up to 700 million euro Mavenclad sales in EU

Merck KGaA eyes up to 700 million euro Mavenclad sales in EU

FRANKFURT (Reuters) - Germany's Merck KGaA is eyeing annual sales of its multiple sclerosis pill Mavenclad, a late-comer to the market for oral treatments against the neurological disease, of up to 700 million euros ($823 million) in the European Union. (Source: Reuters: [Read More]

Merck KGaA eyes up to 700 million eur Mavenclad sales in EU

Merck KGaA eyes up to 700 million eur Mavenclad sales in EU

FRANKFURT (Reuters) - Germany's Merck KGaA is eyeing annual sales of its multiple sclerosis pill Mavenclad, a late-comer to the market for oral treatments against the neurological disease, of up to 700 million euros ($823 million) in the European Union. (Source: Reuters: [Read More]

Caffeine may not relieve movement symptoms for people with Parkinson’s

Caffeine may not relieve movement symptoms for people with Parkinson’s

Contrary to previous research, caffeine may not relieve movement symptoms for people with Parkinson's disease, according to a study published in the September 27, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology. [Read More]

 Page 1 of 31  1  2  3  4  5 » ...  Last » 

Latest Topics

Gut bacteria at young age can contribute to MS disease onset and progression, study suggests

Gut bacteria at young age can contribute to MS disease onset and progression, study suggests

Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age [Read More]

Age and gut bacteria contribute to MS disease progression, according to Rutgers

Age and gut bacteria contribute to MS disease progression, according to Rutgers

(Rutgers University) Gut bacteria at a young age can contribute to multiple sclerosis disease onset and progression. [Read More]

Virtual reality training may be effective alternative to standard therapy after stroke

Virtual reality training may be effective alternative to standard therapy after stroke

Using virtual reality therapy to improve arm and hand movement after a stroke is equally as effective as regular [Read More]

Social care failing people with disabilities, says leading charity

Social care failing people with disabilities, says leading charity

Young people with MS forced to live in care homes for older people Related items fromOnMedica Social care set to eat up [Read More]

World’s Largest MS Research Conference Features Advances in Progressive MS, Myelin Repair, Lifestyle

World’s Largest MS Research Conference Features Advances in Progressive MS, Myelin Repair, Lifestyle

/About-the-Society/News/World’s-Largest-MS-Research-Conference-Features-Ad [Read More]